AGT antibody (AA 34-331)
Quick Overview for AGT antibody (AA 34-331) (ABIN2615130)
Target
See all AGT AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- AA 34-331
-
Specificity
- Human AGT / Angiotensinogen
-
Purification
- Immunoaffinity purified
-
Immunogen
-
Human recombinant protein fragment corresponding to amino acids 34-331 of human AGT (NP_000020) produced in E. coli.
Type of Immunogen: Recombinant protein -
Isotype
- IgG1
-
-
-
-
Application Notes
- Approved: WB (1:500)
-
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, pH 7.3, 1 % BSA, 50 % glycerol, 0.02 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Minimize freezing and thawing.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C. Avoid freeze-thaw cycles.
-
-
- AGT (Angiotensinogen (serpin Peptidase Inhibitor, Clade A, Member 8) (AGT))
-
Alternative Name
- AGT / Angiotensinogen
-
Background
-
Name/Gene ID: AGT
Family: Hormone
Synonyms: AGT, Angiotensin I, ANHU, Angiotensinogen, Pre-angiotensinogen, Angiotensin II, SERPINA8, Serpin A8 -
Gene ID
- 183
-
NCBI Accession
- NP_000020
-
Pathways
- JAK-STAT Signaling, ACE Inhibitor Pathway, EGFR Signaling Pathway, Peptide Hormone Metabolism, Regulation of Systemic Arterial Blood Pressure by Hormones, Regulation of Lipid Metabolism by PPARalpha, Protein targeting to Nucleus, Feeding Behaviour, Monocarboxylic Acid Catabolic Process, Dicarboxylic Acid Transport, Positive Regulation of Response to DNA Damage Stimulus, Regulation of long-term Neuronal Synaptic Plasticity
Target
-